Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials-Reference-Cited by-同舟云学术

Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials

Published:2021-04 Issue:4 Volume:21 Page:529-536
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

DiazGranados Carlos A,Bonaparte Matthew,Wang Hao,Zhu Ming,Lustig Yaniv,Schwartz Eli,Forrat Remi,Dayan Gustavo H,Hodge Shekema,Ataman-Önal Yasemin,Savarino Stephen J

Funder

Sanofi Pasteur

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference19 articles.

1. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013;Stanaway;Lancet Infect Dis,2016

2. Severe dengue in travellers: pathogenesis, risk and clinical management;Halstead;J Travel Med,2019

3. Risk of dengue in travelers: implications for dengue vaccination;Wilder-Smith;Curr Infect Dis Rep,2018

4. Efficacy of a tetravalent dengue vaccine in children in Latin America;Villar;N Engl J Med,2014

5. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial;Capeding;Lancet,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dengue: A review of laboratory diagnostics in the vaccine age;Journal of Medical Microbiology;2024-05-09

2. Advancing arbovirus diagnosis in Brazil: strengthening diagnostic strategies and public health data collection;The Brazilian Journal of Infectious Diseases;2024-05

3. Genomic surveillance reveals that the dengue 2 virus lineage responsible for the 2023-2024 epidemic in the French Caribbean Islands is resistant to Mosnodenvir;2024-04-11

4. A simulation-based method to inform serosurvey design for estimating the force of infection using existing blood samples;PLOS Computational Biology;2023-11-27

5. Identification of prior dengue-naïve Dengvaxia recipients with an increased risk for symptomatic dengue during fever surveillance in the Philippines;Frontiers in Immunology;2023-07-24